NEWS

Research

New Research: How Inherited DNA -Based Mutations Impact Immunotherapy

The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we’ve spoken a lot...

Read More

Part 2 Q&A: Meet the MiraDx Research Team

“We’re pivoting from being focused on the disease to being focused on the patient and providing the tools to personalize each individual’s treatment.” –Mattias

Read More

Top 5 Reasons to Give a Charitable Donation this Holiday Season

This time of year, the malls and online stores are filled with shoppers, eager to purchase the perfect gift for friends and loved ones near and far. We may be biased, but...

Read More

Part 1: Meet the UCLA Research Team Series

As an undergraduate volunteer in Dr. Weidhaas’ laboratory at UCLA, which focuses on the genetics behind cancer, and how it impacts biology—specifically microRNA genetic differences, such as MiraKind’s KRAS-variant, I have an...

Read More

The truth about GWAS and the KRAS-variant

Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice...

Read More

DONATE

SUPPORT OUR RESEARCH

PARTICIPATE

HELP ADVANCE OUR RESEARCH